Asensus Surgical Inc. (ASXC): Price and Financial Metrics


Asensus Surgical Inc. (ASXC): $1.40

-0.03 (-2.10%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ASXC Stock Price Chart Interactive Chart >

Price chart for ASXC

ASXC Price/Volume Stats

Current price $1.40 52-week high $6.95
Prev. close $1.43 52-week low $0.43
Day low $1.39 Volume 3,384,451
Day high $1.51 Avg. volume 14,373,769
50-day MA $1.77 Dividend yield N/A
200-day MA $2.53 Market Cap 328.15M

Asensus Surgical Inc. (ASXC) Company Bio


Asensus Surgical, Inc. is a medical device company, which digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities like augmented intelligence, connectivity and robotics in laparoscopy, and addresses the current clinical, cognitive, economic shortcomings in surgery. The Senhance Surgical System features as the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit (ISU) that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world while staying true to the principles of value-based healthcare. The company was founded by William N. Starling in 2006 and is headquartered in Morrisville, NC.


ASXC Latest News Stream


Event/Time News Detail
Loading, please wait...

ASXC Latest Social Stream


Loading social stream, please wait...

View Full ASXC Social Stream

Latest ASXC News From Around the Web

Below are the latest news stories about Asensus Surgical Inc that investors may wish to consider to help them evaluate ASXC as an investment opportunity.

Asensus Surgical Announces Franklin Medical Center to Initiate the Installation of the Senhance Surgical System

RESEARCH TRIANGLE PARK, N.C., November 15, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Franklin Medical Center in Winnsboro, Louisiana has entered into an agreement to lease and utilize a Senhance® Surgical System.

Yahoo | November 15, 2021

Asensus Surgical EPS in-line, beats on revenue

Asensus Surgical (NYSE:ASXC): Q3 Non-GAAP EPS of -$0.06 in-line; GAAP EPS of -$0.07 misses by $0.01. Revenue of $2.57M (+217.3% Y/Y) beats by $1.55M. Shares -0.54%. Press Release The Company had cash, cash equivalents, short-term and long-term investments, excluding restricted cash of approximately $147.9 million as of September 30, 2021....

Seeking Alpha | November 3, 2021

Asensus Surgical, Inc. (ASXC) CEO Anthony Fernando on Q3 2021 Results - Earnings Call Transcript

Asensus Surgical, Inc. (ASXC) Q3 2021 Earnings Conference Call November 03, 2021 4:30 PM ET Company Participants Mark Klausner - Westwicke, Investor Relations Anthony Fernando - President & Chief Executive Officer Shameze Rampertab - Chief Financial Officer Conference Call Participants Swayampakula Ramakanth - H.C. Wainwright Presentation Operator Thank you for...

SA Transcripts on Seeking Alpha | November 3, 2021

Asensus Surgical, Inc. Reports Operating and Financial Results for the Third Quarter 2021

RESEARCH TRIANGLE PARK, N.C., November 03, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced its operating and financial results for the third quarter 2021.

Yahoo | November 3, 2021

Asensus Surgical Announces Shinmatsudo Central General Hospital in Japan to Initiate Senhance Robotic Surgical System

RESEARCH TRIANGLE PARK, N.C., November 01, 2021--Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the Shinmatsudo Central General Hospital in Matsudo, Japan has entered into an agreement to lease and utilize a Senhance® Surgical System.

Yahoo | November 1, 2021

Read More 'ASXC' Stories Here

ASXC Price Returns

1-mo -17.16%
3-mo -36.36%
6-mo -43.55%
1-year 193.26%
3-year -96.54%
5-year -92.91%
YTD 124.00%
2020 -57.48%
2019 -95.00%
2018 17.10%
2017 48.46%
2016 -47.58%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9659 seconds.